FDA Approves New Gonorrhea Antibiotics Amidst Drug Resistance Concerns
The FDA has recently approved two new oral antibiotics, zoliflodacin and gepotidacin, for the treatment of gonorrhea, marking the first new treatments in decades. These approvals come amid rising cases of gonorrhea and increasing antibiotic resistance to existing treatments. Both medications offer the advantage of oral administration, potentially improving patient access and convenience compared to the current injectable standard of care. Clinical trials demonstrated comparable efficacy and safety profiles for the new drugs.
John Q. Hosedrinker